Loss Contingency, Number Of Cases Remanded

No definition available.

Name:	mrk_LossContingencyNumberOfCasesRemanded
Namespace Prefix:	mrk_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number Of Plaintiffs In Complaint

+ References

No definition available.

+ Details

Name:	mrk_NumberOfPlaintiffsInComplaint
Namespace Prefix:	mrk_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Patent Extension, Term

+ References

No definition available.

+ Details

Name:	mrk_PatentExtensionTerm
Namespace Prefix:	mrk_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Pediatric Exclusivity, Term

+ References

No definition available.

+ Details

Name:	mrk_PediatricExclusivityTerm
Namespace Prefix:	mrk_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Postponement Period Resulting from Litigation

+ References

No definition available.

+ Details

Name:	mrk_PostponementPeriodResultingFromLitigation
Namespace Prefix:	mrk_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(25))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_LitigationReserve
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 720
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483359/720-20-50-1

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 27
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482395/460-10-55-27

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482425/460-10-50-3

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-1

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of claims settled.

+ References

+ Details

Name:	us-gaap_LossContingencyClaimsSettledNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of another entity's patents that the entity has allegedly infringed.

+ References

+ Details

Name:	us-gaap_LossContingencyPatentsAllegedlyInfringedNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of pending claims pertaining to a loss contingency.

+ References

+ Details

Name:	us-gaap_LossContingencyPendingClaimsNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	us-gaap_ValuationAllowancesAndReservesTypeAxis=mrk_LegalDefenseCostsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=mrk_PGRPetitionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=mrk_Dr.SchollsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementGeographicalAxis=country_US
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=mrk_GardasilGardasil9Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementGeographicalAxis=us-gaap_NonUsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationStatusAxis=mrk_MotionForSummaryJudgementGrantedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=mrk_ZetiaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=mrk_BridionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=us-gaap_PatentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=mrk_KeytrudaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=mrk_SubcutaneousPembrolizumabMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=mrk_LynparzaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=mrk_JanuviaJanumetMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Contingencies (Details) $ in Millions					1 Months Ended				3 Months Ended
Contingencies (Details) $ in Millions	Apr. 24, 2025 patent	Mar. 13, 2025	Mar. 15, 2024	Apr. 13, 2023 patent	Feb. 29, 2024 patent	Dec. 31, 2023 case	Jun. 30, 2023	Feb. 28, 2023 patent	Mar. 31, 2025 USD ($) company case	Mar. 21, 2025 plaintiff	Mar. 11, 2025 case	Dec. 31, 2024 USD ($)
Loss Contingencies [Line Items]
Number of plaintiffs in complaint \| plaintiff										7,000,000
Legal Defense Costs
Loss Contingencies [Line Items]
Legal defense costs reserve \| $									$ 230			$ 225
Pending Litigation \| Patents - PGR Petition \| Subsequent Event
Loss Contingencies [Line Items]
Loss contingency, number of patents allegedly infringed \| patent	11
Dr. Scholl's \| U.S. \| Pending Litigation
Loss Contingencies [Line Items]
Loss contingency, pending claims									500
Gardasil/Gardasil 9 \| Non-US \| Pending Litigation
Loss Contingencies [Line Items]
Loss contingency, pending claims									15
Gardasil/Gardasil 9 \| U.S. \| Pending Litigation
Loss Contingencies [Line Items]
Loss contingency, pending claims									245
Gardasil/Gardasil 9 \| U.S. \| Motion for Summary Judgement Granted
Loss Contingencies [Line Items]
Loss contingency, pending claims											16
Zetia \| U.S. \| Pending Litigation
Loss Contingencies [Line Items]
Loss contingency, number of cases remanded						4,000,000
Bridion \| Patents
Loss Contingencies [Line Items]
Loss contingency, claims settled \| company									5
Bridion \| Pending Litigation \| Patents
Loss Contingencies [Line Items]
Loss contingency, pending claims \| company									2
Postponement period resulting from litigation			30 months
Bridion \| Settled Litigation \| Patents
Loss Contingencies [Line Items]
Patent extension, term		5 years					5 years
Pediatric exclusivity, term		6 months
Keytruda \| Pending Litigation \| Patents
Loss Contingencies [Line Items]
Loss contingency, number of patents allegedly infringed \| patent				9
Subcutaneous Pembrolizumab \| Pending Litigation \| Patents \| Subsequent Event
Loss Contingencies [Line Items]
Loss contingency, number of patents allegedly infringed \| patent	15
Lynparza \| Pending Litigation \| Patents
Loss Contingencies [Line Items]
Loss contingency, number of patents allegedly infringed \| patent					1			1
Januvia/Janumet
Loss Contingencies [Line Items]
Loss contingency, claims settled \| company									26